GlassScriptPhysician profile
William L Cody
NPI 1598726697
$2,594.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,210 · 2020: $1,250 · 2022: $135.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,106.49 | 2020 | |
| Abbvie INC. | $390.93 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $157.96 | 2019-2020 | |
| Lupin INC. | $151.56 | 2019 | |
| Medtronic, INC. | $134.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Novo Nordisk INC | $114.57 | 2019 | |
| Minerva Surgical, INC | $96.20 | 2019-2020 | |
| Daiichi Sankyo INC. | $43.67 | 2019 | |
| Therapeuticsmd, INC. | $43.04 | 2019 | |
| Applied Medical Resources Corporation | $43.00 | 2020 | |
| Pfizer INC. | $33.05 | 2019 | |
| Allergan, INC. | $26.24 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.99 | 2019 | |
| Covidien LP | $20.29 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $18.64 | 2019 | |
| Smith+Nephew, INC. | $17.19 | 2019 | |
| Duchesnay USA Incorporated | $16.52 | 2019 | |
| Hologic Sales and Service, LLC | $15.93 | 2019 | |
| Teleflex LLC | $14.48 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.